Company Filing History:
Years Active: 2020
Title: Pat B Zanzonico: Innovator in Cancer Treatment
Introduction
Pat B Zanzonico is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer treatment. His innovative work focuses on optimizing patient-specific therapies to improve outcomes for individuals battling cancer.
Latest Patents
Zanzonico holds a patent for "Systems and methods for determining optimum patient-specific antibody dose for tumor targeting." This patent describes a non-linear compartmental model that utilizes PET-derived data to predict the optimal therapeutic dose of cargo-carrying antibodies, such as radiolabeled antibodies. The model assesses antigen occupancy, residency times in both normal and malignant tissues, and the therapeutic index between cancerous and normal tissues, specifically in colorectal cancer.
Career Highlights
Zanzonico is affiliated with the Memorial Sloan Kettering Cancer Center, where he applies his expertise to advance cancer treatment methodologies. His work is pivotal in developing strategies like multi-step targeting (MST) to enhance therapeutic indices in radioimmunotherapy (RIT).
Collaborations
Throughout his career, Zanzonico has collaborated with esteemed colleagues, including Sarah M Cheal and Steven M Larson, to further research and innovation in cancer therapies.
Conclusion
Pat B Zanzonico's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in targeted therapies for cancer patients.